Drug Prescription Profiles in Patients with Polypharmacy in Spain: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data
| Autor: | Mara Sempere-Manuel, Ignatios Ioakeim-Skoufa, José Ignacio de Juan-Roldán, María Pilar Arroyo-Aniés, Félix Miguel-García, Ermengol Sempere-Verdú, Ramón Orueta-Sánchez, Francisca González-Rubio, Caterina Vicens-Caldentey, Vicente Palop-Larrea, Óscar Esteban-Jiménez, Miguel Ángel Hernández-Rodríguez, Buenaventura Fernández-San José |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Drug Utilization
Drug Adult Male medicine.medical_specialty pharmacoepidemiology Adolescent medicine.drug_class Health Toxicology and Mutagenesis media_common.quotation_subject 030204 cardiovascular system & hematology Drug Prescriptions Article 03 medical and health sciences Young Adult 0302 clinical medicine Internal medicine Electronic prescribing computerized medical records systems medicine Humans 030212 general & internal medicine Medical prescription polypharmacy media_common Polypharmacy Benzodiazepine electronic prescribing real-world data business.industry Public Health Environmental and Occupational Health Pharmacoepidemiology Cross-Sectional Studies Spain Medicine Female business drug utilization Real world data |
| Zdroj: | International Journal of Environmental Research and Public Health Volume 18 Issue 9 International Journal of Environmental Research and Public Health, Vol 18, Iss 4754, p 4754 (2021) |
| ISSN: | 1660-4601 |
| DOI: | 10.3390/ijerph18094754 |
| Popis: | We aimed to identify and compare medication profiles in populations with polypharmacy between 2005 and 2015. We conducted a cross-sectional study using information from the Computerized Database for Pharmacoepidemiologic Studies in Primary Care (BIFAP, Spain). We estimated the prevalence of therapeutic subgroups in all individuals 15 years of age and older with polypharmacy (≥5 drugs during ≥6 months) using the Anatomical Therapeutic Chemical classification system level 4, by sex and age group, for both calendar years. The most prescribed drugs were proton-pump inhibitors (PPIs), statins, antiplatelet agents, benzodiazepine derivatives, and angiotensin-converting enzyme inhibitors. The greatest increases between 2005 and 2015 were observed in PPIs, statins, other antidepressants, and β-blockers, while the prevalence of antiepileptics was almost tripled. We observed increases in psychotropic drugs in women and cardiovascular medications in men. By patient´s age groups, there were notable increases in antipsychotics, antidepressants, and antiepileptics (15–44 years) antidepressants, PPIs, and selective β-blockers (45–64 years) selective β-blockers, biguanides, PPIs, and statins (65–79 years) and in statins, selective β-blockers, and PPIs (80 years and older). Our results revealed important increases in the use of specific therapeutic subgroups, like PPIs, statins, and psychotropic drugs, highlighting opportunities to design and implement strategies to analyze such prescriptions’ appropriateness. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|